465 related articles for article (PubMed ID: 9671775)
1. Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.
Matthews RT; Yang L; Browne S; Baik M; Beal MF
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8892-7. PubMed ID: 9671775
[TBL] [Abstract][Full Text] [Related]
2. Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases.
Beal MF; Matthews RT
Mol Aspects Med; 1997; 18 Suppl():S169-79. PubMed ID: 9266519
[TBL] [Abstract][Full Text] [Related]
3. Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases.
Beal MF
Biofactors; 1999; 9(2-4):261-6. PubMed ID: 10416039
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective strategies for treatment of lesions produced by mitochondrial toxins: implications for neurodegenerative diseases.
Schulz JB; Matthews RT; Henshaw DR; Beal MF
Neuroscience; 1996 Apr; 71(4):1043-8. PubMed ID: 8684608
[TBL] [Abstract][Full Text] [Related]
5. Complex-1 activity and 18F-DOPA uptake in genetically engineered mouse model of Parkinson's disease and the neuroprotective role of coenzyme Q10.
Sharma SK; El Refaey H; Ebadi M
Brain Res Bull; 2006 Jun; 70(1):22-32. PubMed ID: 16750479
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of solanesol against 3-nitropropionic acid-induced Huntington's disease-like behavioral, biochemical, and cellular alterations: Restoration of coenzyme-Q10-mediated mitochondrial dysfunction.
Mehan S; Monga V; Rani M; Dudi R; Ghimire K
Indian J Pharmacol; 2018; 50(6):309-319. PubMed ID: 30783323
[TBL] [Abstract][Full Text] [Related]
7. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate.
Beal MF; Henshaw DR; Jenkins BG; Rosen BR; Schulz JB
Ann Neurol; 1994 Dec; 36(6):882-8. PubMed ID: 7998775
[TBL] [Abstract][Full Text] [Related]
8. Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.
Ferrante KL; Shefner J; Zhang H; Betensky R; O'Brien M; Yu H; Fantasia M; Taft J; Beal MF; Traynor B; Newhall K; Donofrio P; Caress J; Ashburn C; Freiberg B; O'Neill C; Paladenech C; Walker T; Pestronk A; Abrams B; Florence J; Renna R; Schierbecker J; Malkus B; Cudkowicz M
Neurology; 2005 Dec; 65(11):1834-6. PubMed ID: 16344537
[TBL] [Abstract][Full Text] [Related]
9. Role of mitochondria in neuronal cell death induced by oxidative stress; neuroprotection by Coenzyme Q10.
Somayajulu M; McCarthy S; Hung M; Sikorska M; Borowy-Borowski H; Pandey S
Neurobiol Dis; 2005 Apr; 18(3):618-27. PubMed ID: 15755687
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of the neuroprotective role of coenzyme Q10 with or without L-dopa in rotenone-induced parkinsonism.
Abdin AA; Hamouda HE
Neuropharmacology; 2008 Dec; 55(8):1340-6. PubMed ID: 18817789
[TBL] [Abstract][Full Text] [Related]
11. Coenzyme Q10 as a possible treatment for neurodegenerative diseases.
Beal MF
Free Radic Res; 2002 Apr; 36(4):455-60. PubMed ID: 12069110
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of coenzyme Q10 in neurodegenerative diseases.
Beal MF
Methods Enzymol; 2004; 382():473-87. PubMed ID: 15047118
[No Abstract] [Full Text] [Related]
13. Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice.
Sohal RS; Kamzalov S; Sumien N; Ferguson M; Rebrin I; Heinrich KR; Forster MJ
Free Radic Biol Med; 2006 Feb; 40(3):480-7. PubMed ID: 16443163
[TBL] [Abstract][Full Text] [Related]
14. Intrastriatal administration of coenzyme Q10 enhances neuroprotection in a Parkinson's disease rat model.
Park HW; Park CG; Park M; Lee SH; Park HR; Lim J; Paek SH; Choy YB
Sci Rep; 2020 Jun; 10(1):9572. PubMed ID: 32533070
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of coenzyme Q(10) prevents cytochrome c release from mitochondria induced by 1-methyl-4-phenylpyridinium ion in mouse brain synaptosomes.
Mitsumoto Y; Kobayashi S; Matsushima H; Muroyama A; Yoshimura I
Neurosci Lett; 2009 Sep; 463(1):22-5. PubMed ID: 19638300
[TBL] [Abstract][Full Text] [Related]
16. Specificity of coenzyme Q10 for a balanced function of respiratory chain and endogenous ubiquinone biosynthesis in human cells.
Fernández-Ayala DJ; López-Lluch G; García-Valdés M; Arroyo A; Navas P
Biochim Biophys Acta; 2005 Jan; 1706(1-2):174-83. PubMed ID: 15620378
[TBL] [Abstract][Full Text] [Related]
17. [Coenzyme Q10: its biosynthesis and biological significance in animal organisms and in humans].
Siemieniuk E; Skrzydlewska E
Postepy Hig Med Dosw (Online); 2005; 59():150-9. PubMed ID: 15928598
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol-induced neuropathic pain.
Kandhare AD; Ghosh P; Ghule AE; Bodhankar SL
Fundam Clin Pharmacol; 2013 Dec; 27(6):603-22. PubMed ID: 23057828
[TBL] [Abstract][Full Text] [Related]
19. The effects of lifelong ubiquinone Q10 supplementation on the Q9 and Q10 tissue concentrations and life span of male rats and mice.
Lönnrot K; Holm P; Lagerstedt A; Huhtala H; Alho H
Biochem Mol Biol Int; 1998 Apr; 44(4):727-37. PubMed ID: 9584986
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease.
Ferrante RJ; Andreassen OA; Dedeoglu A; Ferrante KL; Jenkins BG; Hersch SM; Beal MF
J Neurosci; 2002 Mar; 22(5):1592-9. PubMed ID: 11880489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
